Alfredo Addeo & Giulio Metro. (2018). First-line alectinib for ALK-positive lung cancer: Is there room for further improvement? BioExcel Publishing Ltd.
Chicago Style (17th ed.) CitationAlfredo Addeo and Giulio Metro. First-line Alectinib for ALK-positive Lung Cancer: Is There Room for Further Improvement? BioExcel Publishing Ltd, 2018.
MLA (9th ed.) CitationAlfredo Addeo and Giulio Metro. First-line Alectinib for ALK-positive Lung Cancer: Is There Room for Further Improvement? BioExcel Publishing Ltd, 2018.
Warning: These citations may not always be 100% accurate.